IV vitamin D product use, by DOPPS country and cross-section

  Paricalcitol only Doxercalciferol only Calcitriol only Other
N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd % N Ptnts Wgtd %
DOPPS Country DOPPS Cross-section 0 0.0% 0 0.0% 14 81.8% 5 18.2%
Canada D4(2010)
D4(2011) 0 0.0% 0 0.0% 17 87.6% 4 12.4%
France D4(2010) 0 0.0% 0 0.0% 0 0.0% 3 100.0%
D4(2011) 0 0.0% 0 0.0% 0 0.0% 8 100.0%
Germany D4(2010) 34 76.5% 0 0.0% 3 6.4% 8 17.1%
D4(2011) 37 71.5% 0 0.0% 5 8.9% 11 19.7%
Italy D4(2010) 164 95.6% 0 0.0% 6 4.4% 0 0.0%
D4(2011) 194 95.0% 0 0.0% 6 5.0% 0 0.0%
Japan D4(2010) 0 0.0% 0 0.0% 165 30.4% 368 69.6%
D4(2011) 0 0.0% 0 0.0% 156 26.7% 441 73.3%
Spain D4(2010) 212 79.1% 0 0.0% 52 17.2% 14 3.7%
D4(2011) 232 84.9% 0 0.0% 34 9.6% 18 5.5%
Sweden D4(2010) 25 41.9% 0 0.0% 0 0.0% 32 58.1%
D4(2011) 23 37.5% 0 0.0% 0 0.0% 34 62.5%
UK D4(2010) 1 8.9% 0 0.0% 0 0.0% 5 91.1%
D4(2011) 1 3.4% 0 0.0% 1 4.6% 12 92.0%
US D4(2010) 2,026 85.4% 386 13.5% 19 0.9% 1 0.1%
D4(2011) 1,779 52.0% 992 47.3% 13 0.4% 2 0.3%

Medications reported as prescribed at end of study month, among all patients

Please see additional methodological information in the Data Sources and Methods section.